Recipharm acquires stake in Nitin Lifesciences
Recipharm acquires 74 per cent of the shares for a purchase consideration of Rs 6,713 million on a cash and debt free basis
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.